UK SACT Board annual conference – 28 November 2023

DON’T FORGET TO REGISTER!

UK SACT Board annual conference – 28 November 2023

The UK SACT Board* will be hosting its Annual Conference at the Pullman London St Pancras Hotel on Tuesday 28 November 2023. Chaired by Dr Tom Roques, Chair of the UKSB and Vice President, Clinical Oncology at The Royal College of Radiologists, this year’s event will include sessions on SACT capacity in the UK, innovation in SACT practice, a forward look to the next decade in cancer care and digital supportive care.

 

Registration is just £25.00 including VAT. CLICK HERE TO REGISTER

For more information, please visit the UKSB website. 

 

We look forward to seeing you at what will surely be an exciting, educational and informative day.

 

* The UK SACT Board (UKSB) provides guidance, oversight and support for the continuing development of SACT services in the UK.

Latest News

By BOPA Education & Training Subcommittee on 8th January 2025

Opportunity for a pharmacist to review the eLearning content for Chronic Lymphocytic Leukaemia

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review…

Read article
By BOPA Passport pillar on 8th January 2025

Request for membership to create or review content for BOPA Digital SACT passport

Dear Member, In order to optimise the user experience of the BOPA SACT Verification Passport, we need to have new and relevant content. The Passport working group would like to…

Read article
By BOPA Committee on 8th January 2025

BOPA Podcast – Let’s Talk About The Future of Healthcare

The next episode of Let’s Talk About SACT is Let’s talk about the future of Healthcare. In this episode we are joined by Julian Barwell. We discuss predictions for what…

Read article
By BOPA Committee on 31st December 2024

New Release: A Joint Consensus Statement by IOCN & British Cardio-Oncology Society – Baseline Cardiac Assessment

The Immuno-Oncology Clinical Network (IOCN) and the British Cardio-Oncology Society (BCOS) are proud to announce the publication of their first joint consensus statement: “Baseline Cardiac Assessment in Individuals Receiving Immune Checkpoint Inhibitors:…

Read article